Bates D
Consultant Neurologist and Senior Lecturer in Neurology, Department of Neurology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, UK.
Int MS J. 2003 Dec;10(4):121.
The success of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is notable, and Chris Polman (Amsterdam, the Netherlands), the new President of ECTRIMS, pointed out that the Congress had grown from an attendance of 50 delegates in 1982 to over 3000 at this 19th meeting. ECTRIMS 2003 provided an overview of recent achievements in clinical multiple sclerosis (MS) research, with sessions highlighting understanding and promoting functional and structural recovery, and the necessity and progress made in co-ordinating research efforts in MS. The impact of molecular biology, new perspectives in MRI and advances in treatment were covered in comprehensive reviews and original presentations. Five hundred stimulating posters from researchers around the world were also presented. Several satellite symposia, a young scientific investigators' session, an international workshop on remyelination in MS, a comprehensive exhibition and presentations of late-breaking research complemented the main programme.
欧洲多发性硬化治疗与研究委员会（ECTRIMS）取得的成功引人注目，ECTRIMS的新任主席克里斯·波尔曼（荷兰阿姆斯特丹）指出，该大会的参会人数已从1982年的50名代表增长到此次第19届会议的3000多人。2003年ECTRIMS会议概述了临床多发性硬化（MS）研究的近期成果，会议环节重点介绍了对功能和结构恢复的理解与促进，以及MS研究协调工作的必要性和进展。分子生物学的影响、MRI的新视角以及治疗进展在全面综述和原创报告中均有涉及。来自世界各地研究人员的500份精彩海报也进行了展示。几场卫星研讨会、一场青年科研人员会议、一场关于MS再髓鞘化的国际研讨会、一场综合展览以及最新研究成果报告对主要议程起到了补充作用。
